Edition:
India

Mike Spector

OxyContin maker Purdue to plead guilty over opioid practices, deal sparks opposition

22 Oct 2020

NEW YORK Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that effectively sidestepped paying billions of dollars in penalties and stopped short of criminally charging its executives or wealthy Sackler family owners. | Video

In emails, Sacklers fret over wealth, opioid business

22 Oct 2020

Soon after a Purdue Pharma LP affiliate pleaded guilty to misbranding its addictive opioid painkiller OxyContin in 2007, the company's Sackler family owners fretted about possible threats to their wealth.

In emails, Sacklers fret over wealth, opioid business

22 Oct 2020

Soon after a Purdue Pharma LP affiliate pleaded guilty to misbranding its addictive opioid painkiller OxyContin in 2007, the company's Sackler family owners fretted about possible threats to their wealth.

In emails, Sacklers fret over wealth, opioid business

22 Oct 2020

Oct 21 Soon after a Purdue Pharma LP affiliate pleaded guilty to misbranding its addictive opioid painkiller OxyContin in 2007, the company's Sackler family owners fretted about possible threats to their wealth.

OxyContin maker Purdue reaches plea deal in opioid probe-sources

21 Oct 2020

NEW YORK, Oct 21 Purdue Pharma LP has reached an agreement to plead guilty to criminal charges over handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that effectively sidesteps paying billions of dollars in penalties and stops short of criminally charging its executives or wealthy Sackler family owners, people familiar with the matter said.

U.S. states oppose settlement being negotiated by OxyContin maker Purdue and Justice Department: letter

15 Oct 2020

NEW YORK A group of 25 state attorneys general oppose a settlement of U.S. opioid probes being negotiated with Purdue Pharma LP and members of the wealthy Sackler family who own it, arguing the deal would improperly entangle state and local officials with future sales of the company's addictive pain drug OxyContin.

EXCLUSIVE-U.S. states oppose settlement being negotiated by OxyContin maker Purdue and Justice Dept -letter

15 Oct 2020

NEW YORK, Oct 14 A group of 25 state attorneys general oppose a settlement of U.S. opioid probes being negotiated with Purdue Pharma LP and members of the wealthy Sackler family who own it, arguing the deal would improperly entangle state and local officials with future sales of the company's addictive pain drug OxyContin.

Exclusive: OxyContin maker Purdue nears guilty plea agreement in U.S. criminal probe - sources

08 Oct 2020

NEW YORK Purdue Pharma LP, the OxyContin maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve U.S. Justice Department probes into its alleged role in fueling the nation's opioid crisis, six people familiar with the matter said. | Video

Exclusive: OxyContin maker Purdue nears guilty plea agreement in U.S. criminal probe - sources

08 Oct 2020

NEW YORK Purdue Pharma LP, the OxyContin maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve U.S. Justice Department probes into its alleged role in fueling the nation’s opioid crisis, six people familiar with the matter said. | Video

Exclusive: Playboy explores deal to return to the stock market - sources

19 Sep 2020

Playboy magazine owner Playboy Enterprises is exploring options that include going public through a merger with a blank-check acquisition company, according to people familiar with the matter.

World News